Feinstein Institutes for Medical Research: Difference between revisions

The Feinstein Institute for Medical Research
Established	1995
Chairman	Ralph Nappi
Dean	Bettie Steinberg
Location	Manhasset, New York, United States
Website	http://www.feinsteininstitute.org

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 22:54, 30 December 2010

The Feinstein Institute for Medical Research is a private, non-profit institution with research programs focusing on immunology, inflammation, neuroscience, and behavioral medicine. The mission is to produce knowledge that will change the way medicine is practiced. It employs ~500 scientists and clinical researchers.

History

The Institute was founded in 1995 in order to support the research operations of the North Shore-LIJ Health System. North Shore University Hospital, in Manhasset, NY, originally constructed a research building in 1985 to foster the growth of clinical and translational science. Clinical research at North Shore University Hospital underwent significant expansion at this time, highlighted by the addition of new laboratories and investigators, abd new technology, including one of the earliest MRI scanners in New York State, and a PET scanner and cyclotron facility that was first on the east coast. By 2010 Feinstein researchers had expanded operations to receive >$45M in federal funding from the National Institutes of Health in order to identify disease mechanisms and drug targets. Their clinical research program annually enrolls >10,000 subjects into clinical research programs.

Science at the Feinstein Institute

Feinstein investigators study the molecular biology and pathophysiology of immunity, autoimmune diseases, cancer, neurodegenerative diseases and neuropsychiatric conditions. They collaborate with other Universities worldwide, and have established an inter-institutional training affiliation with the Karolinska Institute in Stockholm, Sweden. Investigators also collaborate with clinicians in the North Shore-LIJ Health System (including North Shore University Hospital and Long Island Jewish Medical Center) to identify the underlying mechanisms of disease. Patients participate in clinical trials related to the use of experimental drugs that are in various stages of clinical and preclinical testing for cancer, cardiac disease, diabetes, sepsis, shock, trauma, arthritis, and other inflammatory conditions. The volume of National Institutes of Health-funded, patient-oriented research programs in the Feinstein Institute is significant: >90% of the research is categorized as "patient-oriented research," and 65% of these projects are supported by federal grants. The Feinstein is also home to an NIH-funded General Clinical Research Center that offers state-of-the-art facilities for designing, implementing and conducting clinical research studies in a central location; an NIH-funded Early-Phase Schizophrenia Center focuses on the development of the best treatments for schizophrenia; and the Laboratory of Medicinal Biochemistry, which focuses on synthesis of novel molecules as experimental therapeutics, to streamline preclinical testing.

Educational Mission

The Feinstein is the laboratory and faculty home of the Elmezzi Graduate School of Molecular Medicine, an independent, degree-granting institution, chartered by the State University of New York. It confers the PhD degree in Molecular Medicine to students who have previously completed medical school, and then matriculate in a mentored research training program in the Feinstein labs.

Molecular Medicine

The Feinstein publishes Molecular Medicine, an international, peer-reviewed journal that reports on fast-breaking developments in the field of molecular medicine. Its impact factor is ranked in the top 6% of all peer-reviewed journals in biomedical science.

Facts

Operations

>55 laboratories
~2000 research and clinical staff
Home of the Elmezzi Graduate School for Molecular Medicine
Publisher of Molecular Medicine
Kevin J. Tracey, President

Areas of basic interdisciplinary research

biochemistry, structural biology and chemistry
molecular genetics
molecular, cell and developmental biology
immunology, virology and microbiology
medical sciences and human genetics
neuroscience
behavioral disorders

External links

References

@@ Line 1: / Line 1: @@
-The Feinstein Institute for Medical Research is a private, non-profit institution with research programs focusing on immunology, inflammation, neuroscience, and behavioral medicine.  The mission is to prodcue knowledge that will change the way medicine is practiced.  It currently employs over 500 scientists and clinical researchers.
+The Feinstein Institute for Medical Research is a private, non-profit institution with research programs focusing on immunology, inflammation, neuroscience, and behavioral medicine.  The mission is to produce knowledge that will change the way medicine is practiced.  It  employs ~500 scientists and clinical researchers.
 {{Infobox university
@@ Line 62: / Line 62: @@
 ==Science at the Feinstein Institute==
-Feinstein investigators are involved with the study of immunity, autoimmune diseases, cancer, neurodegenerative diseases and neuropsychiatric conditions. The institute collaborates with universites worldwide and has an on-going training agreement with the Karolinska Institute in Stockholm.  Scientists collaborate with clinicians throughout the North Shore-LIJ Health System (including [[North Shore University Hospital]] and [[Long Island Jewish Medical Center]] to identify the underlying mechanisms of disease.  Patients can participate in clinical trials related to the use of experimental drugs that are in various stages of clinical and preclinical testing for cancer, cardiac disease, sepsis, shock, trauma, arthritis, and other inflammatory conditions. The institute is known for its work in autoimmune and inflammatory diseases as well as neurological conditions including  Parkinson's and Alzheimer's. The volume of [[National Institutes of Health]]-funded, patient-oriented research programs in the Feinstein Institute is significant:  Over 80% of their research projects come under the category of patient-oriented research, and nearly 65% of these projects are supported by federal grants.  The Feinstein is also home to an NIH-funded General Clinical Research Center that offers state-of-the-art facilities for designing, implementing and conducting clinical research studies in a central location; the NIH-funded Early-Phase Schizophrenia Center focuses on the development of the best treatments for schizophrenia; and the Laboratory of Medicinal Biochemistry, which focuses on synthesis of novel molecules as experimental therapeutics,  to streamline preclinical testing methods.
+Feinstein investigators study the molecular biology and pathophysiology of immunity, autoimmune diseases, cancer, neurodegenerative diseases and neuropsychiatric conditions.  They collaborate with other Universities worldwide, and have established an inter-institutional training affiliation with the Karolinska Institute in Stockholm, Sweden.  Investigators also  collaborate with clinicians in the [[North Shore-LIJ Health System]] (including [[North Shore University Hospital]] and [[Long Island Jewish Medical Center]]) to identify the underlying mechanisms of disease.  Patients participate in [[clinical trials]] related to the use of experimental drugs that are in various stages of clinical and preclinical testing for cancer, cardiac disease, diabetes, sepsis, shock, trauma, arthritis, and other inflammatory conditions. The volume of [[National Institutes of Health]]-funded, patient-oriented research programs in the Feinstein Institute is significant:  >90% of the research is categorized as "patient-oriented research," and 65% of these projects are supported by federal grants.  The Feinstein is also home to an NIH-funded General Clinical Research Center that offers state-of-the-art facilities for designing, implementing and conducting clinical research studies in a central location; an NIH-funded Early-Phase Schizophrenia Center focuses on the development of the best treatments for schizophrenia; and the Laboratory of Medicinal Biochemistry, which focuses on synthesis of novel molecules as experimental therapeutics,  to streamline preclinical testing.
 ==Educational Mission==
-The Feinstein is home to the Elmezzi Graduate School of Molecular Medicine, an independent degree-granting institution chartered by the State University of New York, which confers medical school graduates, pursuing a career in research, with the PhD degree in molecular medicine.
+The Feinstein is the laboratory and faculty home of the Elmezzi Graduate School of Molecular Medicine, an independent, degree-granting institution, chartered by the State University of New York.  It confers the PhD degree in Molecular Medicine to students who have previously completed medical school, and then matriculate in a mentored research training program in the Feinstein labs.
 ==Molecular Medicine==
-The Feinstein publishes [[Molecular Medicine (journal)|Molecular Medicine]], an international, peer-reviewed journal that reports on fast-breaking developments in molecular medicine.  Its impact factor is ranked in the top 6% of all peer-reviewed journals in biomedical science.
+The Feinstein publishes [[Molecular Medicine (journal)|Molecular Medicine]], an international, peer-reviewed journal that reports on fast-breaking developments in the field of molecular medicine.  Its [[impact factor]] is ranked in the top 6% of all peer-reviewed journals in biomedical science.
 ==Facts==